Capricor Therapeutics
CAPR
#5594
Rank
โ‚น118.02 B
Marketcap
โ‚น2,170
Share price
-2.84%
Change (1 day)
77.89%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: โ‚น118.02 Billion

As of February 2026 Capricor Therapeutics has a market cap of โ‚น118.02 Billion. This makes Capricor Therapeutics the world's 5594th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น118.02 B-16.26%
2025โ‚น140.93 B161.17%
2024โ‚น53.96 B330.48%
2023โ‚น12.53 B55.48%
2022โ‚น8.06 B52.86%
2021โ‚น5.27 B2.18%
2020โ‚น5.16 B981.8%
2019โ‚น0.47 B-46.97%
2018โ‚น0.89 B-65.31%
2017โ‚น2.59 B-32.94%
2016โ‚น3.86 B16.5%
2015โ‚น3.32 B19.33%
2014โ‚น2.78 B18.56%
2013โ‚น2.34 B1943.76%
2012โ‚น0.11 B-89.97%
2011โ‚น1.14 B18.99%
2010โ‚น0.96 B-36.73%
2009โ‚น1.52 B54.13%
2008โ‚น0.98 B-81.03%
2007โ‚น5.20 B3789.04%
2006โ‚น0.13 B-39.43%
2005โ‚น0.22 B3.91%
2004โ‚น0.21 B21.23%
2003โ‚น0.17 B-65.41%
2002โ‚น0.50 B

End of Day market cap according to different sources

On Feb 10th, 2026 the market cap of Capricor Therapeutics was reported to be:

โ‚น115.48 Billion
by Nasdaq info icon info icon
โ‚น121.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น52.445 T 44,338.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.229 T 941.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚น711.57 B 502.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น143.68 B 21.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น2.60 B-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.22 B-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA